id: cardiometabolic_risk_factors_to_major_acute_cardiac_events
name: Cardiometabolic Risk Factors â†’ Major Acute Cardiac Events (MACE)
from_node:
  node_id: cardiometabolic_risk_factors
  node_name: Cardiometabolic Risk Factors
to_node:
  node_id: major_acute_cardiac_events
  node_name: Major Acute Cardiac Events (MACE)
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Metabolic dysfunction including hypertension, diabetes, and dyslipidemia
  increases cardiovascular disease risk'
- 'Step 2: Cirrhosis patients with MASLD phenotype have high burden of cardiometabolic
  risk factors promoting atherosclerosis and cardiac dysfunction'
- 'Step 3: Accumulated cardiovascular risk manifests as major acute cardiac events
  requiring hospitalization'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Catherine Mezzacappa et al. 2025. "Validation and Epidemiologic
    Definition of the Novel Steatotic Liver Disease Nomenclature in a National United
    States Cohort With Cirrhosis.." *Clinical gastroenterology and hepatology : the
    official clinical practice journal of the American Gastroenterological Association*.
    https://doi.org/10.1016/j.cgh.2024.10.035'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.378087'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
